Bausch Health Co. Inc. (BHC) Tops Q1 EPS by 10c; offers guidance
Bausch Health Co. Inc. (NYSE: BHC) reported Q1 EPS of $0.78, $0.10 better than the analyst estimate of $0.68. Revenue for the quarter came in at $2.52 billion versus the consensus estimate of $2.42 billion.
GUIDANCE:
Bausch Health Co. Inc. sees FY2026 revenue of $10.67-10.92 billion, versus the consensus of $10.678 billion.
For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.
